Immunosuppression with Tacrolimus Improved Reproductive Outcome of Women with Repeated Implantation Failure and Elevated Peripheral Blood Th1/Th2 Cell Ratios

@article{Nakagawa2015ImmunosuppressionWT,
  title={Immunosuppression with Tacrolimus Improved Reproductive Outcome of Women with Repeated Implantation Failure and Elevated Peripheral Blood Th1/Th2 Cell Ratios},
  author={Koji Nakagawa and Joanne Kwak‐Kim and Kuniaki Ota and Keiji Kuroda and Michi Hisano and Rikikazu Sugiyama and Koushi Yamaguchi},
  journal={American Journal of Reproductive Immunology},
  year={2015},
  volume={73},
  pages={353 - 361}
}
We evaluated the clinical efficacy of immunosuppressive treatment with tacrolimus for repeated implantation failure (RIF) patients who have elevated in T helper (Th1)/Th2 cytokine producing cell ratios. 
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures
We aim to investigate whether the peripheral blood T helper (Th) 1 cell level could predict pregnancy outcome in patients who have experienced repeated implantation failure (RIF, three or more) after
Increasing number of implantation failures and pregnancy losses associated with elevated Th1/Th2 cell ratio
TLDR
A high Th1/Th2 cell ratio was linked to ≥4 implantation failure cycles and ≥2 pregnancy losses were but not to general infertility.
Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF)
TLDR
The findings suggest that RIF patients with a higher Th1/Th2 ratio could be candidates for tacrolimus therapy and that this immunosuppressive drug could be acting through upregulation of LIF, IL-10, and IL-17.
Potential impact of maternal vitamin D status on peripheral blood and endometrium cellular immunity in women with recurrent implantation failure
This study aims to evaluate the modulatory effects of vitamin D on peripheral blood and endometrial cellular immunity in women with recurrent implantation failure (RIF).
Novel approaches to the management of recurrent pregnancy loss: The OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy
Does the OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy, developed for treating repeated implantation failure (RIF), contribute to
Successful treatment with intrauterine delivery of dexamethasone for repeated implantation failure
TLDR
Effective therapy for endometrial receptivity of patients with repeated embryo implantation failure (RIF) is far undeveloped and whether intrauterine perfusion of dexamethasone (DXM), local administration of drugs with less systematic side‐effects, and suppressing uterine NK (uNK) cells to improve endometrian receptivity remains unknown.
Analysis of the risk factors and treatment for repeated implantation failure: OPtimization of Thyroid function, IMmunity, and Uterine Milieu (OPTIMUM) treatment strategy
What are the pregnancy outcomes after the OPtimization of Thyroid function, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy in patients with repeated implantation failure (RIF)?
Obstetric and perinatal outcome of the women with repeated implantation failures or recurrent pregnancy losses who received pre‐ and post‐conception tacrolimus treatment
TLDR
The clinical efficacy of tacrolimus in women with repeated implantation failures (RIF) of immune etiologies and its safety for women with RIF undergoing assisted reproductive technology cycles and their babies is reported.
Alteration in endometrial helper T‐cell subgroups in chronic endometritis
The effect of chronic endometritis (CE) on the subpopulation of CD4+ T cells, Th1, Th2, Th17, and regulatory T cells in the endometrium is unknown.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
Effect of Intravenous Immunoglobulin Treatment on the Th1/Th2 Balance in Women with Recurrent Spontaneous Abortions
TLDR
A possible effect of IvIg on the T helper cell (Th1/Th2) balance was investigated in abortions of either alloimmune or autoimmune abnormalities.
Expression of Intracellular Th1 and Th2 Cytokines in Women with Recurrent Spontaneous Abortion, Implantation Failures after IVF/ET or Normal Pregnancy
TLDR
Investigation of absolute counts of intracellular T helper 1 and Th2 cytokine expressing T‐cell subpopulations in women with three or more recurrent spontaneous abortions, multiple implantation failures after in‐vitro fertilization and embryo transfer (IVF/ET) or during normal pregnancy finds nothing.
ORIGINAL ARTICLE: Serial Estimation of Th1:Th2 Cytokines Profile in Women Undergoing In‐Vitro Fertilization‐Embryo Transfer
To investigate changes in the ratio of T‐cell subpopulations expressing intracellular T helper1 (Th1) and T helper 2 (Th2) cytokines in women with a history of recurrent failed implantation under
Degree of TNF‐α/IL‐10 Cytokine Elevation Correlates With IVF Success Rates in Women Undergoing Treatment With Adalimumab (Humira) and IVIG
Citation Winger EE, Reed JL, Ashoush S, El‐Toukhy T, Ahuja S, Taranissi M. Degree of TNF‐α/IL‐10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab
REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T‐Cell Paradigm in Pregnancy
TLDR
Th1/Th2/Th17 and regulatory T‐cell paradigm in pregnancy and the role of ‘silent’ and ‘active’ T‐cells in pregnancy are studied.
Intravenous Immunoglobulin for Repeated IVF Failure and Unexplained Infertility
TLDR
Whether intravenous immunoglobulin (IVIG) improves in vitro fertilization (IVF) success rates in women with a difficult history of multiple IVF failures and /or ‘unexplained’ infertility is investigated.
How safe are anti-rheumatic drugs during pregnancy?
Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF.
TLDR
The prevalence of dominant Th1 immune responses in peripheral blood lymphocytes may reflect the systemic contribution of Th1 cytokines to RSA or multiple implantation failures in IVF cycles.
Investigation and current management of recurrent IVF treatment failure in the UK
TLDR
Current practice in the management of recurrent in vitro fertilisation (IVF) treatment failure in licensed UK infertility centres is determined.
...
1
2
3
4
5
...